Cytochrome P450 2E1 polymorphism in gastric cancer in Brazil: Case-control studies of Japanese Brazilians and non-Japanese Brazilians

被引:0
|
作者
Nishimoto, IN
Hanaoka, T
Sugimura, H
Nagura, K
Ihara, M
Li, XJ
Arai, T
Hamada, GS
Kowalski, LP
Tsugane, S
机构
[1] Hamamatsu Univ Sch Med, Dept Pathol 1, Hamamatsu, Shizuoka 4313192, Japan
[2] Hosp Santa Cruz, Res Ctr, Nikkei Dis Prevent Ctr, BR-04122000 Sao Paulo, SP, Brazil
[3] Natl Canc Ctr Res Inst E, Epidemiol & Biostat Div, Kashiwa, Chiba 2778577, Japan
[4] AC Camargo Canc Hosp, Res Ctr, Div Epidemiol & Biostat, BR-01509900 Sao Paulo, SP, Brazil
[5] AC Camargo Canc Hosp, Res Ctr, Dept Head & Neck Surg, BR-01509900 Sao Paulo, SP, Brazil
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Cytochrome P450 2E1 (Cyp2E1) is involved in the metabolic oxidation of carcinogenic nitroso compounds, including N-nitrosoamines. There is an RsaI polymorphism in the transcriptional regulatory region of this gene, and in vitro evidence suggests that the variant type of this polymorphic site has higher transcriptional activity but less chlorzoxazone-metabolizing activity. Interindividual differences in the metabolic capacity of Cyp2E1 are assumed to be associated with cancer susceptibility, but the results of the previous studies on the relation between Cyp2E1 RsaI polymorphism and cancer susceptibility have been inconsistent. Two case-control studies of gastric cancer in Japanese Brazilians (96 cases, 192 controls) and Brazilians not of Japanese ancestry (non-Japanese Brazilians; 236 cases, 236 controls) in Sao Paulo were designed to clarify the role of the Cyp2E1 RsaI genotype in susceptibility to gastric cancer after considering multifactorial environmental influences. The subjects with variant RsaI genotypes amounted to 47% (28 of 59) and 48% (64 of 133), respectively of the Japanese cases and controls, and 6% (11 of 187) and 10% (19 of 192), respectively, of the non-Japanese cases and controls. As expected, a difference in the distributions of the two groups was observed. The odds ratio of the RsaI variant genotype of Cyp2E1 was 0.46 (95% confidence interval, 0.21-1.04) in the non-Japanese Brazilian population and 0.98 (95% confidence interval, 0.50-1.90) in the Japanese Brazilian population after adjusting for sex, age, tobacco use, and meat consumption. Additional adjustment for potential confounding factors did not change the odds ratio substantially. No significant interactions were observed between the polymorphism and environmental factors, In regard to the histological type of gastric cancer, the variant genotype was significantly more prevalent than the common genotype in Japanese subjects with diffuse type gastric cancer, Our study suggests that the Cyp2E1 RsaI polymorphism is associated with a reduced risk of gastric cancer, although how the assumed increase in Cyp2E1 expression produced by this polymorphism is related to a reduced risk of cancer remains unclear. The observations in this study are consistent with the recent observations of esophageal cancer in endemic areas of China.
引用
收藏
页码:675 / 680
页数:6
相关论文
共 50 条
  • [31] Clinical isoflurane metabolism by cytochrome P450 2E1
    Kharasch, ED
    Hankins, DC
    Cox, K
    ANESTHESIOLOGY, 1999, 90 (03) : 766 - 771
  • [32] Identification of cytochrome P450 2E1 in rat brain
    Yoo, M
    Ryu, HM
    Shin, SW
    Yun, CH
    Lee, SC
    Ji, YM
    You, KH
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1997, 231 (02) : 254 - 256
  • [33] Cytochrome P450 2E1 polymorphism and nasopharyngeal carcinoma development in Thailand: a correlative study
    Kongruttanachok, N
    Sukdikul, S
    Setavarin, S
    Kerekhjanarong, V
    Supiyaphun, P
    Voravud, N
    Poovorawan, Y
    Mutirangura, A
    BMC CANCER, 2001, 1 (1)
  • [34] Cytochrome P450 2E1 polymorphism and nasopharyngeal carcinoma development in Thailand: a correlative study
    Narisorn Kongruttanachok
    Sairoong Sukdikul
    Surachai Setavarin
    Verachai Kerekhjanarong
    Pakpoom Supiyaphun
    Narin Voravud
    Yong Poovorawan
    Apiwat Mutirangura
    BMC Cancer, 1
  • [35] Cytochrome P450 2E1 polymorphism as an antituberculous agents-induced liver injury
    Suhuyanly, Nella
    Gani, Rino Alvani
    Syam, Ari Fahrial
    Rumende, Cleopas Martin
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2014, 29 : 205 - 205
  • [36] Cytochrome P450 2E1 DraI polymorphisms in lung cancer in minority populations
    Wu, XF
    Amos, CI
    Kemp, BL
    Shi, HH
    Jiang, H
    Wan, Y
    Spitz, MR
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 1998, 7 (01) : 13 - 18
  • [37] Human Cytochrome P450 2E1 metabolizes acrylamide to glycidamide
    Settels, Eva
    Bernauer, Ulrike
    Palavinskas, Richard
    Klaffke, Horst Stefan
    Gundert-Remy, Ursula
    Appel, Klaus Erich
    TOXICOLOGY LETTERS, 2007, 172 : S108 - S109
  • [38] A comprehensive review of cytochrome P450 2E1 for xenobiotic metabolism
    Chen, Jingxuan
    Jiang, Sibo
    Wang, Jin
    Renukuntla, Jwala
    Sirimulla, Suman
    Chen, Jianjun
    DRUG METABOLISM REVIEWS, 2019, 51 (02) : 178 - 195
  • [39] Inactivation of cytochrome P450 2E1 by tert-butylisothiocyanate
    Kent, UM
    Roberts, ES
    Chun, J
    Hodge, K
    Juncaj, J
    Hollenberg, PF
    CHEMICAL RESEARCH IN TOXICOLOGY, 1998, 11 (10) : 1154 - 1161
  • [40] Homology modeling of cytochrome P450 2E1 enzyme.
    Tropsha, A
    Waller, CL
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1996, 211 : 84 - COMP